Microvesicle-associated tissue factor and Trousseau's syndrome

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 1, 2007, Pages 70-74

  Del Conde, I ^a   Bharwani, L D ^b   Dietzen, D J ^c   Pendurthi, U ^d   Thiagarajan, P ^b,e   López, José A ^f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^e MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Microvesicles; Thrombosis; Tissue factor; Trousseau's syndrome

Indexed keywords

ANTICOAGULANT AGENT; CLOPIDOGREL; LEPIRUDIN; LIPOCORTIN; LOW MOLECULAR WEIGHT HEPARIN; PHYCOERYTHRIN; THROMBOPLASTIN; WARFARIN;

ADULT; ARTICLE; CANCER CELL; CASE REPORT; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEART INFARCTION; HUMAN; HYPERCOAGULABILITY; IMMUNOHISTOCHEMISTRY; KIDNEY INFARCTION; LUNG CANCER; MALE; MICROVASCULATURE; PLASMA FACTOR; PRIORITY JOURNAL; SPLEEN INFARCTION; THROMBOSIS; TROUSSEAU SYNDROME;

BLOOD COAGULATION; CARCINOMA, GIANT CELL; CYTOPLASMIC VESICLES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VIIA; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS; LUNG NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; REFERENCE VALUES; SYNDROME; THROMBOPLASTIN; THROMBOSIS;

EID: 33845549003     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02301.x     Document Type: Article

References (26)

1. Donati MB. Cancer and thrombosis. Haemostasis 1994; 24: 128-31.
2. Trousseau A. Phlegmasia alba dolens. Clinique medicinale de lHotel-Dieu de Paris. London: The New Sydenham Society, 1865.
3. Wahrenbrock M, Borsig L, Le D, Varki N, Varki A. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 2003; 112: 853-62.
4. Bell WR, Starksen NF, Tong S, Porterfield JK. Trousseau's syndrome. Devastating coagulopathy in the absence of heparin. Am J Med 1985; 79: 423-30.
5. Sack Jr GH, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) 1977; 56: 1-37.
6. Falanga A, Gordon SG. Isolation and characterization of cancer procoagulant: A cysteine proteinase from malignant tissue. Biochemistry 1985; 24: 5558-67.
7. Rao LV. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev 1992; 11: 249-66.
8. del Conde I, Shrimpton CN, Thiagarajan P, López JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106: 1604-11.
9. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 18205-12.
10. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: A circulating, soluble, thrombogenic protein. Nat Med 2003; 9: 458-62.
11. Dietzen DJ, Jack GG, Page KL, Tetzloff TA, Hall CL, Mast AE. Localization of tissue factor pathway inhibitor to lipid rafts is not required for inhibition of factor VIIa/tissue factor activity. Thromb Haemost 2003; 89: 65-73.
12. Bach RR. Initiation of coagulation by tissue factor. CRC Crit Rev Biochem 1988; 23: 339-68.
13. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 1087-97.
14. Callander N, Rapaport SI. Trousseau's syndrome. West J Med 1993; 158: 364-71.
15. Kenney WE. The association of carcinoma in the body and tail of the pancreas with multiple venous thrombi. Surgery 1943; 14: 600-9.
16. McKay DG, Mansell H, Hertig AT. Carcinoma of the body of the pancreas with fibrin thrombosis and fibrinogenopenia. Cancer 1953; 6: 862-9.
17. Dvorak HF, Quay SC, Orenstein NS, Dvorak AM, Hahn P, Bitzer AM, Carvalho AC. Tumor shedding and coagulation. Science 1981; 212: 923-4.
18. Warr TA, Rao LV, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: Effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990; 75: 1481-9.
19. McKay DG. Clinical significance of intravascular coagulation. Bibl Haematol 1983; 49: 63-78.
20. Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, Celi A, Croce K, Furie BC, Furie B. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197: 1585-98.
21. Moore KL, Stults NL, Diaz S, Smith DF, Cummings RD, Varki A, McEver RP. Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol 1992; 118: 445-56.
22. Koenig A, Norgard-Sumnicht K, Linhardt R, Varki A. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest 1998; 101: 877-89.
23. Muller M, Albrecht S, Golfert F, Hofer A, Funk RH, Magdolen V, Flossel C, Luther T. Localization of tissue factor in actin-filament-rich membrane areas of epithelial cells. Exp Cell Res 1999; 248: 136-47.
24. Randolph GJ, Luther T, Albrecht S, Magdolen V, Muller WA. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood 1998; 92: 4167-77.
25. Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettila V, Artigas A, Percell SR, et.al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial. JAMA 2003; 290: 238-47.
26. Morrow DA, Murphy SA, McCabe CH, Mackman N, Wong HC, Antman EM. Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): Results of the PROXIMATE-TIMI 27 trial. Eur Heart J 2005; 26: 682-8.